These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8187011)

  • 1. Is there an alternative to alternating adjuvant therapy for breast cancer?
    Hudis C
    Cancer Invest; 1994; 12(3):329-35. PubMed ID: 8187011
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy--clinical trials and laboratory models.
    Wittes RE
    Cancer Treat Rep; 1986 Jan; 70(1):87-103. PubMed ID: 3510738
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant systemic therapy in breast cancer; a review.
    Mouridsen HT; Palshof T
    Eur J Cancer Clin Oncol; 1983 Dec; 19(12):1753-70. PubMed ID: 6363091
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental basis and clinical reality of preoperative (neoadjuvant) chemotherapy in breast cancer.
    Ragaz J; Goldie JH; Baird R; Rebbeck P; Basco V; Coldman A
    Recent Results Cancer Res; 1989; 115():28-35. PubMed ID: 2623337
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adjuvant therapy in breast cancer].
    Semiglazov VF
    Vopr Onkol; 2000; 46(1):18-27. PubMed ID: 10789218
    [No Abstract]   [Full Text] [Related]  

  • 6. [Up-to-date treatment of breast cancer. Myeloblastic chemotherapy and hematopoietic cell grafting].
    Jerusalem G
    Rev Med Liege; 1997 Feb; 52(2):76-9. PubMed ID: 9173487
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast cancer studies yield mixed results on high-dose chemotherapy with stem cell support.
    Miller SL
    Am J Health Syst Pharm; 1999 May; 56(10):939. PubMed ID: 10365714
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose chemotherapy and autologous bone marrow support for breast cancer.
    Peters WP
    Important Adv Oncol; 1991; ():135-50. PubMed ID: 1869274
    [No Abstract]   [Full Text] [Related]  

  • 9. High dose chemotherapy with haemopoietic support for breast cancer.
    Steward WP
    Eur J Cancer; 1995; 31A Suppl 7():S21-4. PubMed ID: 8562187
    [No Abstract]   [Full Text] [Related]  

  • 10. Dose intensity for breast cancer.
    Armstrong DK; Davidson NE
    Oncology (Williston Park); 2001 Jun; 15(6):701-8, 712; discussion 712-4, 717-8. PubMed ID: 11430205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative and conventionally timed chemotherapy in operable breast cancer.
    Goldhirsch A
    Recent Results Cancer Res; 1985; 98():106-13. PubMed ID: 3839931
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy dose and schedule in adjuvant treatment of breast cancer: phoenix, turkey, or dodo?
    Crown J
    Lancet; 2003 Aug; 362(9385):677-8. PubMed ID: 12957087
    [No Abstract]   [Full Text] [Related]  

  • 13. Average relative dose intensity and the impact on design of clinical trials.
    Hryniuk WM
    Semin Oncol; 1987 Mar; 14(1):65-74. PubMed ID: 3823917
    [No Abstract]   [Full Text] [Related]  

  • 14. Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy.
    Balduzzi A; Leonardi MC; Cardillo A; Orecchia R; Dellapasqua S; Iorfida M; Goldhirsch A; Colleoni M
    Cancer Treat Rev; 2010 Oct; 36(6):443-50. PubMed ID: 20304562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of drug dose, timing and radiotherapy in adjuvant therapy of breast cancer.
    Buzdar AU; Smith TL; Marcus CE; Hortobagyi GN; Blumenschein GR
    Recent Results Cancer Res; 1984; 96():141-7. PubMed ID: 6396767
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent developments in the use of systemic adjuvant therapy for the treatment of breast cancer.
    Fisher B; Wickerham DL; Redmond C
    Semin Oncol; 1992 Jun; 19(3):263-77. PubMed ID: 1344973
    [No Abstract]   [Full Text] [Related]  

  • 17. Estrogen deprivation therapy and colon cancer risk in breast cancer patients.
    Malaka DO; Olopade OI
    Breast J; 2010; 16(1):110-2. PubMed ID: 19929891
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of DCIS--results from clinical trials.
    Cuzick J
    Surg Oncol; 2003 Dec; 12(4):213-9. PubMed ID: 14998562
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer.
    Vollmer RT
    J Natl Cancer Inst; 1999 Feb; 91(3):286-7. PubMed ID: 10037109
    [No Abstract]   [Full Text] [Related]  

  • 20. Rationale for the use of alternating non-cross-resistant chemotherapy.
    Goldie JH; Coldman AJ; Gudauskas GA
    Cancer Treat Rep; 1982 Mar; 66(3):439-49. PubMed ID: 7060033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.